Publication | Open Access
Acute Lymphoblastic Leukemia
70
Citations
0
References
2012
Year
Hematological MalignancyMedicineMixed-phenotype Acute LeukemiaMalignant Blood DisorderClinical EpidemiologyHematologyPathologyAcute Lymphoblastic LeukemiaMyeloid NeoplasiaClassical HematologyPhiladelphia Chromosome StatusAdult T-cell Leukemia-lymphomaOncologyCancer ResearchNccn GuidelinesRadiologyHealth Sciences
The inaugural NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for acute lymphoblastic leukemia (ALL) were developed as a result of meetings convened by a multi-disciplinary panel of experts in 2011. These NCCN Guidelines provide recommendations on the diagnostic evaluation and workup for ALL, risk assessment, risk-stratified treatment approaches based on the Philadelphia chromosome status and age (adults vs. adolescents/young adults), assessment of minimal residual disease, and supportive care considerations. It is recommended that patients be treated at specialized centers with expertise in the management of ALL.